Literature DB >> 1833420

The plasminogen activator/plasmin system.

J D Vassalli1, A P Sappino, D Belin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1833420      PMCID： PMC295552          DOI： 10.1172/JCI115405

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  48 in total

1.  Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor.

Authors:  C Longstaff; P J Gaffney
Journal:  Biochemistry       Date:  1991-01-29       Impact factor: 3.162

Review 2.  Growth factor control of extracellular proteolysis.

Authors:  D B Rifkin; D Moscatelli; J Bizik; N Quarto; F Blei; P Dennis; R Flaumenhaft; P Mignatti
Journal:  Cell Differ Dev       Date:  1990-12-02

3.  Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.

Authors:  C S HE; S M Wilhelm; A P Pentland; B L Marmer; G A Grant; A Z Eisen; G I Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Characterization of the cellular binding site for the urokinase-type plasminogen activator.

Authors:  A Estreicher; A Wohlwend; D Belin; W D Schleuning; J D Vassalli
Journal:  J Biol Chem       Date:  1989-01-15       Impact factor: 5.157

5.  Plasminogen activator inhibitor-1 is induced in microvascular endothelial cells by a chondrocyte-derived transforming growth factor-beta.

Authors:  M S Pepper; R Montesano; L Orci; J D Vassalli
Journal:  Biochem Biophys Res Commun       Date:  1991-04-30       Impact factor: 3.575

6.  Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin.

Authors:  H J Ehrlich; J Keijer; K T Preissner; R K Gebbink; H Pannekoek
Journal:  Biochemistry       Date:  1991-01-29       Impact factor: 3.162

7.  Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.

Authors:  M Ploug; E Rønne; N Behrendt; A L Jensen; F Blasi; K Danø
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

Review 8.  Plasminogen receptors in the mediation of pericellular proteolysis.

Authors:  E F Plow; L A Miles
Journal:  Cell Differ Dev       Date:  1990-12-02

9.  Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain.

Authors:  M J Gething; B Adler; J A Boose; R D Gerard; E L Madison; D McGookey; R S Meidell; L M Roman; J Sambrook
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

10.  Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.

Authors:  A P Sappino; J Huarte; D Belin; J D Vassalli
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539
View more
  225 in total

Review 1.  Proteases at the endometrial-trophoblast interface: their role in implantation.

Authors:  Lois A Salamonsen; Guiying Nie
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.

Authors:  Z Y Hu; Y X Liu; K Liu; S Byrne; T Ny; Q Feng; C D Ockleford
Journal:  J Anat       Date:  1999-02       Impact factor: 2.610

Review 3.  A fibrin based model for rheumatoid synovitis.

Authors:  O Sánchez-Pernaute; R Largo; E Calvo; M A Alvarez-Soria; J Egido; G Herrero-Beaumont
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

Review 4.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

5.  Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia.

Authors:  S Guller; Z Tang; Y Y Ma; S Di Santo; R Sager; H Schneider
Journal:  Placenta       Date:  2010-11-11       Impact factor: 3.481

6.  Role of hypoxia-inducible transcription factors 1alpha and 2alpha in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell line.

Authors:  E S Meade; Y Y Ma; S Guller
Journal:  Placenta       Date:  2007-06-13       Impact factor: 3.481

7.  Single-nucleotide polymorphism of the urokinase-plasminogen activator gene during aging and transformation of human diploid kidney cell cultures.

Authors:  Safedin H Beqaj; David Post; Jon M Ryan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Sep-Oct       Impact factor: 2.416

8.  Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge.

Authors:  Margaret R Gyetko; Sudha Sud; Stephen W Chensue
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.

Authors:  Nilima Biswas; Sucheta M Vaingankar; Manjula Mahata; Madhusudan Das; Jiaur R Gayen; Laurent Taupenot; Justin W Torpey; Daniel T O'Connor; Sushil K Mahata
Journal:  Endocrinology       Date:  2007-11-08       Impact factor: 4.736

10.  Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53.

Authors:  C Kunz; S Pebler; J Otte; D von der Ahe
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.